CCC

Capstone Therapeutics Corp

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪255.61 K‬USD
−31.27USD
‪2.32 M‬USD
‪61.56 M‬USD
‪35.71 K‬
Beta (1Y)
0.51

About Capstone Therapeutics Corp

CEO
Michael M. Toporek
Headquarters
Tempe
Employees (FY)
52
Founded
1987
FIGI
BBG000BGYFL7
Capstone Therapeutics Corp. is a biotechnology company. It develops a pipeline of novel therapeutic peptides and other molecules aimed at helping patients with under-served medical conditions. The company was founded in July 1987 and is headquartered in Tempe, AZ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CAPS is 5.00 USD — it has decreased by 3.85% in the past 24 hours. Watch Capstone Therapeutics Corp stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Capstone Therapeutics Corp stocks are traded under the ticker CAPS.
Capstone Therapeutics Corp is going to release the next earnings report on May 30, 2024. Keep track of upcoming events with our Earnings Calendar.
CAPS stock is 4.00% volatile and has beta coefficient of 0.51. Track Capstone Therapeutics Corp stock price on the chart and check out the list of the most volatile stocks — is Capstone Therapeutics Corp there?
Yes, you can track Capstone Therapeutics Corp financials in yearly and quarterly reports right on TradingView.
CAPS stock has fallen by 3.85% compared to the previous week, the month change is a 3.85% fall, over the last year Capstone Therapeutics Corp has showed a 86.49% decrease.
CAPS net income for the last quarter is ‪−609.00 K‬ USD, while the quarter before that showed ‪−77.00 K‬ USD of net income which accounts for −690.91% change. Track more Capstone Therapeutics Corp financial stats to get the full picture.
Today Capstone Therapeutics Corp has the market capitalization of ‪255.61 K‬, it has decreased by 4.72% over the last week.
No, CAPS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CAPS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Capstone Therapeutics Corp stock right from TradingView charts — choose your broker and connect to your account.
CAPS reached its all-time high on May 28, 1996 with the price of 26750.00 USD, and its all-time low was 4.90 USD and was reached on Nov 17, 2023. View more price dynamics on CAPS chart.
See other stocks reaching their highest and lowest prices.
As of May 10, 2024, the company has 52.00 employees. See our rating of the largest employees — is Capstone Therapeutics Corp on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Capstone Therapeutics Corp technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Capstone Therapeutics Corp stock shows the sell signal. See more of Capstone Therapeutics Corp technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Capstone Therapeutics Corp EBITDA is ‪266.00 K‬ USD, and current EBITDA margin is 6.88%. See more stats in Capstone Therapeutics Corp financial statements.